SEA-BCMA

DB18309InvestigationalProtein Based Therapies

SEA-BCMA: Overview.

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 17
Curator reviewed
Also known as: Anti-bcma antibody sea-bcma · Nonfucosylated humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting B-cell maturation antigen (SEA-BCMA)

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with SEA-BCMA, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.